View Article

  • Formulation and Pharmacological Evaluation of a Polyherbal Hydrogel Containing Aloe vera, Curcumin, and Centella asiatica for Diabetic Wound Healing Activity: A Comprehensive Review and Methodological Framework

  • Late Laxmibai Phadtare College of Pharmacy A/P-Kalamb-Walchandnagar,Tal : Indapur Dist : Pune

Abstract

Background: Diabetic wound healing is a complex and challenging clinical problem, characterized by a self-perpetuating cycle of oxidative stress, chronic inflammation, impaired angiogenesis, and defective extracellular matrix (ECM) remodeling. Conventional wound dressings often provide passive care and fail to address this multifactorial pathophysiology.Objective: This review outlines the scientific rationale, formulation design, and comprehensive evaluation strategy for a polyherbal hydrogel containing standardized extracts of Aloe vera, curcumin (Curcuma longa), and Centella asiatica. The objective is to create a bioactive dressing that synergistically targets multiple pathways to accelerate diabetic wound repair.Methods: We review the pathophysiology of diabetic wounds and the pharmacological actions of the selected herbs. A detailed experimental methodology is provided, covering pre-formulation studies, hydrogel development using modern polymer science (e.g., Carbopol/HPMC), Quality-by-Design (QbD) principles, and advanced evaluation techniques. This includes physicochemical characterization (rheology, bio-adhesion), in vitro release kinetics, and biological assays (antioxidant, antimicrobial, cell migration). A robust in vivo protocol using a streptozotocin (STZ)-induced diabetic rat excision wound model is detailed, with endpoints including wound contraction rate, histopathology (collagen, angiogenesis via CD31/VEGF), and biochemical markers (hydroxyproline, MDA, TNF-?). Expected Outcomes: The proposed polyherbal hydrogel is expected to maintain a moist wound environment while actively promoting healing. Aloe vera will provide hydration and support re-epithelialization; curcumin will offer potent antioxidant and anti-inflammatory effects; and Centella asiatica will stimulate fibroblast proliferation and collagen synthesis. This multi-pronged approach is hypothesized to lead to faster wound closure, enhanced tissue quality, and reduced infection risk compared to untreated or single-agent controls. Conclusion: A well-formulated and rigorously evaluated polyherbal hydrogel represents a promising, next-generation therapeutic strategy for managing chronic diabetic wounds. This manuscript provides a complete framework to guide its development from concept to preclinical validation

Keywords

Diabetic Wound, Hydrogel, Aloe vera, Curcumin, Centella asiatica, Wound Healing, Polyherbal, Drug Delivery, Tissue Regeneration

Introduction

× Popup Image

Diabetes mellitus has reached pandemic proportions, and its complications represent a significant global health burden. Among the most debilitating of these is the diabetic foot ulcer (DFU), a chronic, non-healing wound that is a leading cause of non-traumatic lower-limb amputations [1]. The pathophysiology of diabetic wounds is notoriously complex, involving a vicious cycle of hyperglycemia, peripheral neuropathy, vascular insufficiency, oxidative stress, and a persistent, non-resolving inflammatory state [2]. This hostile microenvironment impairs all phases of the normal wound healing cascade, from cell proliferation and migration to angiogenesis and matrix remodeling [3].

Conventional wound dressings, such as gauze or films, primarily offer a passive protective barrier. While advanced dressings (e.g., foams, alginates) provide better moisture management, they do not actively intervene in the underlying biological defects of the diabetic wound [4]. There is a critical unmet need for "active" or "bioactive" dressings that can modulate the wound environment to promote healing.

Hydrogels—three-dimensional, hydrophilic polymer networks—are exceptional platforms for modern wound care. They can donate moisture to dry wounds, absorb excess exudate, are biocompatible, and can be designed to provide sustained, localized delivery of therapeutic agents [5]. This makes them ideal vehicles for delivering phytochemicals with known wound-healing properties.

This review focuses on the development of a sophisticated polyherbal hydrogel combining three powerhouse botanicals: Aloe vera, curcumin (from Curcuma longa), and Centella asiatica (Gotu Kola).

  • Aloe vera is renowned for its hydrating and soothing properties, primarily driven by the polysaccharide acemannan, which stimulates fibroblast growth and epithelialization [6, 7].
  • Curcumin is a potent antioxidant and anti-inflammatory agent that can quench reactive oxygen species (ROS) and downregulate pro-inflammatory cytokines like TNF-α and IL-6, which are chronically elevated in diabetic wounds [8, 9].
  • Centella asiatica contains bioactive triterpenes (asiaticoside, madecassoside) that are proven to enhance collagen synthesis, improve tensile strength of newly formed skin, and promote angiogenesis [10, 11].

By combining these three agents in a single hydrogel formulation, we hypothesize a synergistic effect that addresses multiple facets of diabetic wound pathology simultaneously (Figure 1). This manuscript provides a comprehensive scientific framework for the formulation, characterization, and pharmacological evaluation of this novel polyherbal therapeutic system.

FIGURE 1: DUAL MECHANISM OF DIABETIC WOUNDS AND HYDROGEL THERAPY

Figure 1: Pathophysiology vs. Therapeutic Action

This diagram illustrates how the polyherbal hydrogel is designed to counteract the key pathological defects present in a chronic diabetic wound.

2. RATIONALE FOR THE POLYHERBAL APPROACH

A single-agent therapy is often insufficient to overcome the multifaceted barriers in diabetic wound healing. A polyherbal approach, as summarized in Table 1, allows for a synergistic, multi-pronged attack on the wound's pathophysiology.

TABLE 1: PATHOPHYSIOLOGY OF DIABETIC WOUNDS AND CORRESPONDING HERBAL ACTIONS

 

Pathological Feature in Diabetic Wound

Pharmacological Action of Herbal Component

↑ Oxidative Stress & ROS Damage

Curcumin: Potent ROS scavenger, upregulates antioxidant enzymes (e.g., Nrf2 pathway).

↑ Chronic Inflammation (High TNF-α, IL-6)

Curcumin & Aloe vera: Inhibit NF-κB signaling, reducing pro-inflammatory cytokine production.

↓ Impaired Angiogenesis

Centella asiatica & Curcumin: Stimulate Vascular Endothelial Growth Factor (VEGF) production, promoting new blood vessel formation.

↓ Defective Collagen Synthesis & ECM

Centella asiatica: Triterpenes (asiaticoside) directly stimulate fibroblast proliferation and Type I collagen synthesis.

↓ Impaired Re-epithelialization

Aloe vera: Acemannan stimulates keratinocyte migration and proliferation.

High Risk of Microbial Colonization

Hydrogel Barrier, Curcumin, & Aloe vera: Provide a physical barrier and possess intrinsic antimicrobial properties.

Wound Dehydration / Excessive Exudate

Hydrogel Base: Maintains optimal moisture balance by donating or absorbing water.

 

3. FORMULATION DESIGN AND METHODOLOGY

The successful development of the hydrogel relies on rational selection of excipients and a carefully controlled manufacturing process (Figure 2).

FIGURE 2: FORMULATION AND EVALUATION WORKFLOW

Figure 2: Comprehensive Development Workflow

This workflow diagram outlines the systematic steps from raw material selection to final preclinical evaluation, incorporating modern pharmaceutical development principles like Quality-by-Design (QbD) and Design of Experiments (DoE).

3.1. MATERIALS AND METHODS

3.1.1. Materials

Standardized extracts of Aloe vera (≥10% acemannan), Curcuma longa (≥95% curcuminoids), and Centella asiatica (≥40% triterpenes) will be procured. Pharmaceutical-grade polymers (Carbopol 940, HPMC K100M), humectants (propylene glycol), neutralizers (triethanolamine), and solubilizers for curcumin (e.g., Polysorbate 80, HP-β-Cyclodextrin) will be used.

3.1.2. Pre-formulation Studies

Solubility of extracts in various solvents will be determined. Drug-excipient compatibility will be assessed using Fourier-Transform Infrared Spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC) to detect any potential interactions.

3.1.3. Formulation of the Hydrogel

A detailed breakdown of components is provided in Table 2. The hydrogel will be prepared by dispersing the gelling agent (e.g., Carbopol 940) in purified water, followed by the addition of other polymers and humectants. The herbal extracts and solubilized curcumin will be incorporated with gentle mixing. Finally, the pH will be adjusted to ~6.0 using triethanolamine to induce gelation.

4. PHARMACOLOGICAL EVALUATION (IN VIVO)

4.1. Experimental Animals

Healthy adult Wistar rats (180–220 g) of either sex will be used. The study protocol will be approved by the Institutional Animal Ethics Committee (IAEC).

4.2. Induction of Diabetes

Diabetes will be induced by a single intraperitoneal (i.p.) injection of Streptozotocin (STZ) at a dose of 55 mg/kg, dissolved in cold citrate buffer (pH 4.5). Animals with fasting blood glucose levels >250 mg/dL after 72 hours will be considered diabetic and selected for the study.

4.3. Excision Wound Model

The diabetic rats will be anesthetized, and the dorsal thoracic region will be shaved. A circular, full-thickness excision wound of approximately 200 mm² will be created using a sterile biopsy punch.

TABLE 2: COMPONENTS AND RATIONALE FOR THE POLYHERBAL HYDROGEL FORMULATION

 

Component

Example

Concentration (% w/w)

Rationale / Function

Gelling Agent

Carbopol® 940

0.5 – 1.5

Creates the primary hydrogel network; provides viscosity.

Viscosity Modifier

HPMC K100M

0.5 – 2.0

Modulates viscosity, improves bio-adhesion and controls release.

Humectant

Propylene Glycol

5 – 10

Prevents the dressing from drying out; acts as a co-solvent.

Curcumin Solubilizer

HP-β-Cyclodextrin or Polysorbate 80

1:2 molar ratio or 1-5%

Enhances solubility and stability of poorly soluble curcumin.

Active 1

Aloe vera extract

1 – 5

Provides healing polysaccharides (acemannan) and hydration.

Active 2

Curcumin

0.1 – 0.5

Serves as the primary antioxidant and anti-inflammatory agent.

Active 3

Centella asiatica extract

0.5 – 2

Delivers triterpenes to stimulate collagen and angiogenesis.

Neutralizing Agent

Triethanolamine (TEA)

q.s. to pH 6.0

Neutralizes Carbopol to form the viscous gel structure.

Vehicle

Purified Water

q.s. to 100

The primary solvent and hydrating medium.

3.2. Evaluation of the Polyherbal Hydrogel

A comprehensive set of evaluation parameters (Table 3) will be used to ensure the quality, safety, and efficacy of the final formulation.

TABLE 3: COMPREHENSIVE EVALUATION PARAMETERS FOR THE HYDROGEL

Category

Parameter

Method / Instrument

Acceptance Criteria

Physicochemical

Appearance & Homogeneity

Visual Inspection

Homogeneous, smooth, free of lumps

pH

pH meter

5.5 – 6.5 (skin compatible)

Viscosity & Rheology

Brookfield Viscometer / Rheometer

Appropriate viscosity for topical application (e.g., 20,000-50,000 cP)

Spreadability

Parallel Plate Method

Good spreadability circle diameter

Bio-adhesion

Texture Analyzer

Adequate force of detachment

Performance

Drug Content Uniformity

HPLC

90% – 110% of label claim

In Vitro Release Test

Franz Diffusion Cell

Sustained release over 8-12 hours

Biological

In Vitro Antioxidant Activity

DPPH/ABTS Assay

Significant radical scavenging activity

In Vitro Antimicrobial Activity

Agar Well Diffusion

Zone of inhibition against S. aureusP. aeruginosa

In Vivo Efficacy

Wound Contraction Rate

Digital Planimetry

Significantly faster closure vs. control

Histopathology

H&E and Masson's Trichrome Staining

Enhanced collagen deposition, re-epithelialization, angiogenesis

Biochemical Markers

ELISA / Colorimetric Assays

↑ Hydroxyproline, ↓ MDA, ↓ TNF-α

Safety

Dermal Irritation Test

OECD Guideline 404 (Rabbit model)

Non-irritant

Stability

ICH Stability Studies

Stability Chamber

Stable for at least 6 months under accelerated conditions

 

4.4. Experimental Groups

The animals will be divided into the following groups (n=6 per group):

  • Group I: Normal Control (non-diabetic, untreated wound)
  • Group II: Diabetic Control (untreated wound)
  • Group III: Diabetic + Placebo Hydrogel (hydrogel base without herbal extracts)
  • Group IV: Diabetic + Standard Drug (e.g., Povidone-Iodine ointment)
  • Group V: Diabetic + Polyherbal Hydrogel

4.5. Treatment and Evaluation

The formulations will be applied topically to the wound area once daily for 21 days. Wound contraction will be measured every 3rd day by tracing the wound boundary on a transparent sheet and calculating the area. The period of epithelialization will be noted as the number of days required for the scar to fall off completely.

On day 21, animals will be euthanized, and wound tissue will be collected for:

  • Histopathological Analysis: Tissue sections stained with Hematoxylin & Eosin (H&E) and Masson’s Trichrome will be evaluated for collagen deposition, re-epithelialization, inflammatory cell infiltration, and angiogenesis.
  • Biochemical Analysis: Tissue homogenates will be analyzed for hydroxyproline content (a marker of collagen), malondialdehyde (MDA, a marker of oxidative stress), and levels of inflammatory cytokines (TNF-α, IL-6).

FIGURE 3: PROPOSED MECHANISM OF ACTION OF INDIVIDUAL HERBAL COMPONENTS

Figure 3: Multi-Target Action of Herbal Components

 

This mind map illustrates how the three herbal actives work on distinct yet complementary pathways to promote holistic wound repair.

CONCLUSION

The development of a polyherbal hydrogel containing Aloe vera, curcumin, and Centella asiatica presents a scientifically robust and highly promising strategy for the management of chronic diabetic wounds. By combining the hydrating and sustained-release benefits of a hydrogel vehicle with the synergistic, multi-target pharmacological actions of the selected botanicals, this formulation is poised to address the core pathological defects that hinder healing in diabetic patients. The comprehensive methodological framework outlined in this review, from QbD-based formulation to rigorous in vivo evaluation, provides a clear roadmap for translating this concept from the laboratory bench to a potential clinical application. Successful validation would mark a significant advancement in active wound care, offering a safer, more effective, and plant-based alternative for this major unmet medical need.

REFERENCES

  1. Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2017). Diabetic foot ulcers and their recurrence. The New England Journal of Medicine, 376(24), 2367–2375.
  2. Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of Dental Research, 89(3), 219–229.
  3. Reinke, J. M., & Sorg, H. (2012). Wound repair and regeneration. European Surgical Research, 49(1), 35–43.
  4. Jones, V., Grey, J. E., & Harding, K. G. (2006). Wound dressings. BMJ, 332(7544), 777–780.
  5. Hoffman, A. S. (2012). Hydrogels for biomedical applications. Advanced Drug Delivery Reviews, 64(Suppl), 18–23.
  6. Surjushe, A., Vasani, R., & Saple, D. G. (2008). Aloe vera: A short review. Indian Journal of Dermatology, 53(4), 163–166.
  7. Choonhakarn, C., Busaracome, P., Sripanidkulchai, B., & Sarakarn, P. (2010). The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. British Journal of Dermatology, 162(3), 633–638.
  8. Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92.
  9. Akbik, D., Ghadiri, M., Chrzanowski, W., & Rohanizadeh, R. (2014). Curcumin as a wound healing agent. Life Sciences, 116(1), 1–7.
  10. Brinkhaus, B., Lindner, M., Schuppan, D., & Hahn, E. G. (2000). Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiaticaPhytomedicine, 7(5), 427–448.
  11. Shukla, A., Rasik, A. M., & Dhawan, B. N. (1999). Asiaticoside-induced elevation of antioxidant levels in healing wounds. Phytotherapy Research, 13(1), 50–54.
  12. Boateng, J. S., Matthews, K. H., Stevens, H. N. E., & Eccleston, G. M. (2008). Wound healing dressings and drug delivery systems: A review. Journal of Pharmaceutical Sciences, 97(8), 2892–2923.

Reference

  1. Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2017). Diabetic foot ulcers and their recurrence. The New England Journal of Medicine, 376(24), 2367–2375.
  2. Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of Dental Research, 89(3), 219–229.
  3. Reinke, J. M., & Sorg, H. (2012). Wound repair and regeneration. European Surgical Research, 49(1), 35–43.
  4. Jones, V., Grey, J. E., & Harding, K. G. (2006). Wound dressings. BMJ, 332(7544), 777–780.
  5. Hoffman, A. S. (2012). Hydrogels for biomedical applications. Advanced Drug Delivery Reviews, 64(Suppl), 18–23.
  6. Surjushe, A., Vasani, R., & Saple, D. G. (2008). Aloe vera: A short review. Indian Journal of Dermatology, 53(4), 163–166.
  7. Choonhakarn, C., Busaracome, P., Sripanidkulchai, B., & Sarakarn, P. (2010). The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. British Journal of Dermatology, 162(3), 633–638.
  8. Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92.
  9. Akbik, D., Ghadiri, M., Chrzanowski, W., & Rohanizadeh, R. (2014). Curcumin as a wound healing agent. Life Sciences, 116(1), 1–7.
  10. Brinkhaus, B., Lindner, M., Schuppan, D., & Hahn, E. G. (2000). Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiaticaPhytomedicine, 7(5), 427–448.
  11. Shukla, A., Rasik, A. M., & Dhawan, B. N. (1999). Asiaticoside-induced elevation of antioxidant levels in healing wounds. Phytotherapy Research, 13(1), 50–54.
  12. Boateng, J. S., Matthews, K. H., Stevens, H. N. E., & Eccleston, G. M. (2008). Wound healing dressings and drug delivery systems: A review. Journal of Pharmaceutical Sciences, 97(8), 2892–2923.

Photo
Sanskruti Pandekar
Corresponding author

Late Laxmibai Phadtare College of Pharmacy A/P-Kalamb-Walchandnagar,Tal : Indapur Dist : Pune.

Photo
Ulka Mote
Co-author

Late Laxmibai Phadtare College of Pharmacy A/P-Kalamb-Walchandnagar,Tal : Indapur Dist : Pune.

Photo
Dr. Pravin Uttekar
Co-author

Late Laxmibai Phadtare College of Pharmacy A/P-Kalamb-Walchandnagar,Tal : Indapur Dist : Pune.

Photo
Sagar Daitkar
Co-author

Late Laxmibai Phadtare College of Pharmacy A/P-Kalamb-Walchandnagar,Tal : Indapur Dist : Pune.

Sanskruti Pandekar, Ulka Mote, Dr. Pravin Uttekar, Sagar Daitkar, Formulation and Pharmacological Evaluation of a Polyherbal Hydrogel Containing Aloe vera, Curcumin, and Centella asiatica for Diabetic Wound Healing Activity: A Comprehensive Review and Methodological Framework, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 6, 2297-2304, https://doi.org/10.5281/zenodo.20609791

More related articles
Role of CDSCO in Drug Approval in India...
Nidhi Mahato, Gulfsha Parveen...
Emerging Trends in Curcumin -Loaded SNEDDS for Bra...
Shreya Pawar, Malsheete R.B., Karbhari Vaishnavi , Kapale Maheshw...
Formulation And Evaluation of Poly-Herbal Medicate...
Bhorakade S.B, Ingole R.D., Shrikhande B.V., Pabale P.V., Dipake ...
Related Articles
Development and Characterization of Lipid Nanocapsule-Based Ocular Drug Delivery...
Gitanjali Sarvade, Mr. Nishinandan Shinde, Dr. Ravi Kurhade, Dr. Mahesh Patil...
Formulation and Evaluation of Polyherbal Neuro-Calming Preparation Using Mimosa ...
Monali Shinde, Dr. Kiran Shinde, Kalyani Sawant, Sheetal Sanap, Dattatray Bhawar, Anushka Ayyar...
Comprehensive Review of Pharmaceutical Granulation: Modern Paradigms, Process Me...
Navnath Shinde, Dr. Sushil Kumar Shinde, Snehal Gandhat, Pratiksha Sarode, Taufik Shaikh, Ajay Wa...
Role of CDSCO in Drug Approval in India...
Nidhi Mahato, Gulfsha Parveen...
More related articles
Role of CDSCO in Drug Approval in India...
Nidhi Mahato, Gulfsha Parveen...
Emerging Trends in Curcumin -Loaded SNEDDS for Brain Disorder from Nanoformulati...
Shreya Pawar, Malsheete R.B., Karbhari Vaishnavi , Kapale Maheshwari, Ankita Bardapure, VijayendraSw...
Formulation And Evaluation of Poly-Herbal Medicated Baby Shampoo...
Bhorakade S.B, Ingole R.D., Shrikhande B.V., Pabale P.V., Dipake A.c., Gaikwad V.S....
Role of CDSCO in Drug Approval in India...
Nidhi Mahato, Gulfsha Parveen...
Emerging Trends in Curcumin -Loaded SNEDDS for Brain Disorder from Nanoformulati...
Shreya Pawar, Malsheete R.B., Karbhari Vaishnavi , Kapale Maheshwari, Ankita Bardapure, VijayendraSw...
Formulation And Evaluation of Poly-Herbal Medicated Baby Shampoo...
Bhorakade S.B, Ingole R.D., Shrikhande B.V., Pabale P.V., Dipake A.c., Gaikwad V.S....